Thymosin Alpha 1 (Zadaxin)
Overview
A 28-amino acid peptide originally isolated from thymic tissue (thymosin fraction 5) that serves as a potent immunomodulator. Thymosin alpha 1 enhances T-cell maturation, dendritic cell function, and antibody responses by activating Toll-like receptors (TLR2, TLR9) on innate immune cells.
Mechanism of Action
It promotes Th1 immune responses and augments vaccine efficacy while modulating inflammatory cytokine production.
Research Summary & Key Findings
Approved in over 35 countries (not FDA-approved) for hepatitis B, hepatitis C, and as an immune adjuvant. Clinical trials showed improved virologic response rates in chronic hepatitis B when combined with interferon. Used during COVID-19 pandemic based on observational data suggesting reduced mortality in critically ill patients (Wu et al., Clin Infect Dis, 2020). Phase 3 trials for hepatocellular carcinoma adjuvant therapy showed trends toward improved survival.
Clinical Status
Thymosin Alpha 1 (Zadaxin) is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.
Administration Routes
References
Primary literature
- PubMed — "Thymosin Alpha 1"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov — "Thymosin Alpha 1"
Registered interventional and observational studies, including status and phase.
- PubChem — "Thymosin Alpha 1"
Chemical structure, molecular properties, and bioactivity data.
Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.
Related Peptides in Immune
Thymalin
InvestigationalA peptide bioregulator originally extracted from bovine thymus gland, consisting of a mixture of polypeptides that modul...
View detailsLL-37
Research PhaseThe only human cathelicidin antimicrobial peptide, a 37-amino acid cationic peptide cleaved from the precursor protein h...
View detailsVIP (Vasoactive Intestinal Peptide)
InvestigationalA 28-amino acid neuropeptide widely distributed in the central and peripheral nervous systems and immune cells. VIP acts...
View detailsThymopentin (TP-5)
InvestigationalA synthetic pentapeptide (Arg-Lys-Asp-Val-Tyr) corresponding to residues 32-36 of thymopoietin, a thymic hormone involve...
View detailsStart Your Consultation
Get an AI-proposed Thymosin Alpha 1 (Zadaxin) protocol reviewed by a physician in our network.
Start Your ConsultationFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Thymosin Alpha 1 (Zadaxin).
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.